SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Analysts/Investors Conference Call17-11-2022
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Analysts/Investors Conference CallSMS PHARMACEUTICALS LTD. - 532815 - Investor Presentation On Q2 FY 2022-23
Investor Presentation on Q2 FY 2022-23SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Financial ResultsSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Rescheduled Intimation of Investor's Conference CallSMS PHARMACEUTICALS LTD. - 532815 - Standalone And Consolidated Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2022
standalone and consolidated un-audited Financial Results for the quarter and half year ended 30th September, 2022SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 12-Nov-2022 To Consider Financial Statements For The Period Ended September 2022
outcome of the Board Meeting held on 12-Nov-2022 to consider financial statements for the period ended September 2022SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor's Conference CallSMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Second Quarter And Half Year Ended 30Th September, 2022.
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve un-audited Financial Results for the second quarter and half year ended 30th September, 2022.SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Credit Rating
Credit Rating Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Acquisition
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 for Investment in LLP